A5103245114- Liver Disease Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Advanced Radiotherapy Techniques
- Liver Disease and Transplantation
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
- Endoplasmic Reticulum Stress and Disease
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Medical Imaging Techniques and Applications
- Parasitic infections in humans and animals
- Management of metastatic bone disease
- Radiation Therapy and Dosimetry
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Mathematical Biology Tumor Growth
- Radiopharmaceutical Chemistry and Applications
- Endometrial and Cervical Cancer Treatments
- Cancer Genomics and Diagnostics
- Colorectal and Anal Carcinomas
- Vascular Anomalies and Treatments
- Gallbladder and Bile Duct Disorders
- COVID-19 and healthcare impacts
- Congenital Anomalies and Fetal Surgery
- Glioma Diagnosis and Treatment
- Microbial Inactivation Methods
Campus Bio Medico University Hospital
2024
Università Campus Bio-Medico
2014-2022
Ospedale D. Cotugno
2007
Universidad de la República
1982
University of Turin
1947

 Background & Aims: Disappearance of portal blood flow and arterial vascularization is the hallmark hepatocarcinogenesis. The capability a dynamic imaging modality detecting hypervascularization small nodules crucial to promote rapid diagnostic therapeutic work-up improving survival. We aimed evaluate CEUS detect ≤ 2 cm HCC arising during surveillance so as shorten work-up.
 Methods: From October 2009 September 2014, among 1757 consecutive cirrhotic patients under with...
To compare in a randomized controlled trial (RCT) 3-year survival of cirrhotic patients with hepatocellular carcinoma (HCC) accompanied by portal vein tumor thrombus (PVTT) treated sorafenib plus percutaneous radiofrequency ablation (RFA) both intraparenchymal HCC and PVTT (combination Group) or alone (sorafenib-alone Group).Ninety-nine consecutive Child A cirrhotics were to receive RFA main (MPVTT) (n=49) (n=50).One-, 2- rates 60%, 35% 26%, respectively, the combination group 37% 0 % at 1-...
Background and Aims: To report long-term results in treatment of intermediate hepatocellular carcinoma (HCC) cirrhotics using new high-powered microwaves (MWS) ablation alone. Methods: This multicenter study included 215 (age range: 67-84 years; 137 males; 149 Child A, 66 B) who underwent percutaneous ultrasound-guided MWS instead transarterial chemoembolization. Among the patient population, 109 had a single nodule (Ø 5.3-8 cm) [group A], 70 2 nodules 3-6 B] 36 3-5 1.5-6.8 C]. efficacy was...
Research Articles| March 17 2010 Sur la nature de l'innervation du muscle ciliaire Brücke-Wallace l'homme Subject Area: Ophthalmology P. Matteucci Travail Clinique Opbtalmologique l’Université Turin [Directeur : Prof. L. Guglianetti] Search for other works by this author on: This Site PubMed Google Scholar Ophthalmologica (1947) 114 (6): 377–383. https://doi.org/10.1159/000300497 Article history Published Online: Content Tools Views Icon contents Figures & tables Video Audio Supplementary...
(1) Background: This study aims to assess the safety and efficacy of fractionated SRT (fSRT) pertuzumab-trastuzumab (PT) in patients with breast cancer brain metastases (BCBM). (2) Methods: Patients HER2+ BCBM who received FSRT from 2015 2019 were identified. included if they treated fSRT within 21 days receiving PT. All lesions LINAC-based a total dose 27 Gy delivered three consecutive fractions. concurrent evaluated 4-6 weeks after SRS subsequently every 2-3 months MRI re-imaging (3)...
Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination early diagnosis of hepatoma, complications their preventions treatments, etc.
In human epidermal growth factor receptor 2 (HER2+) expressing breast cancer subtype, the incidence of brain metastases is common and patients often die due to uncontrolled cranial disease. This a case report HER2+ woman with diffuse that experienced long survival clinical benefit from multiple radiotherapy treatments combined systemic therapy, without increased toxicity.